Question

Difficulty: MediumGeneral Internal Medicine

A 54-year-old woman is evaluated on the general medical ward for new-onset chills and a temperature of 38.8°C (101.8°F). She recently completed her second cycle of systemic chemotherapy for invasive ductal carcinoma. Laboratory studies demonstrate a white blood cell count of 900/mm³ and an absolute neutrophil count of 250/mm³. Her blood pressure is 110/70 mm Hg, pulse is 105/min, and respiratory rate is 18/min. Physical examination reveals an indwelling central venous port in the right upper chest with no overlying erythema, fluctuance, or tenderness. The remainder of the examination is unremarkable.

Arrange the following steps in the most appropriate chronological order for the acute diagnostic and therapeutic management of this patient.

  1. 1Obtain peripheral and central venous blood cultures
  2. 2Administer an empiric antipseudomonal beta-lactam antibiotic
  3. 3Continue the initial empiric antibiotic regimen and monitor clinical status for 48 to 72 hours
  4. 4Add an empiric intravenous antifungal agent if fever persists beyond 4 to 7 days

Answer

The correct sequence is to first obtain peripheral and central blood cultures, followed immediately by empiric antipseudomonal beta-lactam antibiotics. The patient is then monitored for 48 to 72 hours on this initial regimen, and an empiric antifungal agent is added only if fever persists beyond 4 to 7 days.
The management of neutropenic fever relies on a protocolized sequence to balance the risk of overwhelming sepsis against antimicrobial stewardship principles. Because these patients lack a robust inflammatory response, infections can progress rapidly. The immediate first step is obtaining blood cultures (including from any central lines) to maximize pathogen recovery. Immediately after cultures are drawn, broad-spectrum empiric antibiotics with antipseudomonal coverage (e.g., cefepime, meropenem) must be initiated within 60 minutes. The median time to defervescence is 2 to 5 days; therefore, the initial regimen should be continued without alteration for 48 to 72 hours if the patient remains hemodynamically stable. If unexplained fever persists beyond 4 to 7 days despite appropriate antibacterial coverage, the risk of an invasive fungal infection increases substantially, warranting the addition of an empiric antifungal agent.

Step-by-Step Solution

1
Draw peripheral and central venous blood cultures.
Pathogens present in the bloodstream are captured before exposure to antibiotics.
Maximizes the diagnostic yield, allowing for subsequent targeted antimicrobial de-escalation.
2
Administer broad-spectrum antipseudomonal antibiotics.
Immediate coverage against life-threatening bacterial pathogens (e.g., Pseudomonas aeruginosa) is provided.
Neutropenic patients lack the immune cells required to localize infections, making rapid empiric coverage essential.
3
Monitor the patient for 48 to 72 hours without altering the antibiotic regimen.
Adequate time is given for the initial antibiotics to take effect.
The median time to defervescence in neutropenic fever is 2 to 5 days; premature escalation in a stable patient is unwarranted.
4
Initiate empiric antifungal therapy if unexplained fever persists after 4 to 7 days.
Occult invasive fungal infections are treated.
Prolonged neutropenia and broad-spectrum antibiotic use significantly increase the risk for fungal infections (e.g., Candida, Aspergillus).

Key Concept

Algorithmic management of febrile neutropenia
Estimated Time:1m 30s
Rate this question